| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/02/1989 | US4826825 Foods, drugs, cosmetics, chemicals, dessication |
| 05/02/1989 | US4826680 Pharmaceutical composition containing thymus extract fractions |
| 05/02/1989 | CA1253422A1 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays |
| 04/26/1989 | EP0313533A1 Food-stuff and a process for its preparation |
| 04/26/1989 | EP0313515A1 A polypeptide growth factor from milk |
| 04/26/1989 | EP0313348A2 Device and method for depletion of the leukocyte content of blood and blood components |
| 04/26/1989 | EP0312595A1 Blood component separator |
| 04/25/1989 | US4824945 Hypocholesterolemically active RNA fractions |
| 04/25/1989 | US4824673 New drugs based on extracts of algae, and corresponding formulations |
| 04/20/1989 | WO1989003429A1 Recombinant avipox virus |
| 04/20/1989 | WO1989003222A1 Soluble human cd4 fragments and uses therefor |
| 04/20/1989 | WO1989002469A3 Human erythroid-specific transcriptional enhancer |
| 04/19/1989 | EP0312423A2 Antiparasitic agents, processes for their production, and antiparasitic compositions, especially antimalerials containing these agents |
| 04/19/1989 | EP0312246A2 Inhibitor of angiogenesis |
| 04/19/1989 | EP0312114A2 Cryoprotectant solution and method |
| 04/19/1989 | EP0311950A2 Procedure for preparing a sterile plasme protein solution, which contains fibrinogen and coagulation factor XIII |
| 04/19/1989 | EP0311866A1 Treatment of lipoprotein anomalies linked to cholesterol metabolism |
| 04/18/1989 | US4822877 Modified haem |
| 04/18/1989 | US4822872 Preferential adsorption of impurities on water insoluble carrier with amine or aldehyde ligands |
| 04/18/1989 | US4822608 Synergistic action with antibiotics |
| 04/18/1989 | US4822607 Anti-tumor agent and method |
| 04/18/1989 | US4822512 Inorganic halides and oxidizers form hypohalites; dry mixture also contains sulfamic acid, non-reducing organic acid, alkali metal phosphates |
| 04/18/1989 | CA1252948A1 Process for purifying proteins |
| 04/18/1989 | CA1252745A1 Antibiotic a26201-1 and antibiotic a26201-2 produced by a strain of actinoplanes |
| 04/18/1989 | CA1252744A1 Ultrapurification of factor ix and other vitamin k- dependent proteins |
| 04/18/1989 | CA1252716A1 Lipoprotein adsorbent for use in extracorporeal circulation treatment and process for preparing thereof |
| 04/12/1989 | EP0311469A2 Transformed lactic acid bacteria |
| 04/12/1989 | EP0311091A1 Isotonic lipid emulsions containing omega-3 fatty acids and the use thereof |
| 04/12/1989 | EP0310757A1 Manufacturing process of a propolis-ethanol extract |
| 04/12/1989 | EP0310639A1 Omega-3 fatty acids in traumatic injury treatment. |
| 04/11/1989 | US4820731 Parenteral dietary supplement and method of minimizing effects of infection through diet |
| 04/06/1989 | WO1989002748A1 Reduction of low density lipoproteins in biological fluids |
| 04/06/1989 | WO1989002743A1 In vitro method for the induction of the spermatozoal acrosome reaction and application of said method to the assessment of spermatozoa and the treatment of male-related infertility |
| 04/06/1989 | WO1989002736A1 Siderophores as antiparasitic agents |
| 04/05/1989 | EP0310410A2 Control of calcium activated potassium efflux from injured body cells |
| 04/05/1989 | EP0310317A2 Inactivation of viruses and bacteria |
| 04/05/1989 | EP0310316A2 TGEV-virus of swine as a dog vaccine |
| 04/05/1989 | EP0309787A2 Process for producing a highly purified, virus-free and biologically active transferrin preparation |
| 04/05/1989 | EP0309532A1 Phamaceutical composition, for oral administration, designed to attenuate the effects of -lactamines |
| 04/05/1989 | EP0309477A1 Ecteinascidins 729, 743, 745, 759a, 759b and 770. |
| 04/05/1989 | EP0309456A1 Process for replicating bone marrow. |
| 04/04/1989 | US4818763 Immunostimulants |
| 04/04/1989 | US4818698 Polypeptides and preparation process thereof |
| 03/30/1989 | DE3730857A1 Fango paraffin for heat therapy |
| 03/30/1989 | DE3730556A1 Multilipid-based medicine |
| 03/29/1989 | EP0308456A1 Compositon for the treatment of the epiderm. |
| 03/29/1989 | EP0308407A1 Method and machine based on the principle of centrifugation for cytapheresis such as platelet apheresis, and for plasma exchange treatment. |
| 03/29/1989 | EP0144367B1 Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin |
| 03/28/1989 | US4816561 Biologically active polypeptides |
| 03/28/1989 | US4816441 Anticarcinogenic agents, viricides |
| 03/28/1989 | US4816416 Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions |
| 03/28/1989 | US4816254 Ointment for treating skin irritations |
| 03/28/1989 | US4816251 Tissue adhesives, heat treatment, vacuum |
| 03/28/1989 | US4816162 Filtration, sterilization |
| 03/23/1989 | WO1989002469A2 Human erythroid-specific transcriptional enhancer |
| 03/23/1989 | WO1989002459A1 Method of reducing glial scar formation and promoting axon growth |
| 03/23/1989 | WO1989002305A1 Leucocyte-separating filter |
| 03/23/1989 | WO1989002304A1 Leucocyte-separating filter |
| 03/23/1989 | WO1989002275A1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures |
| 03/23/1989 | WO1989002274A1 Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets |
| 03/23/1989 | WO1989002273A1 Method of washing blood cells and container assembly therefor |
| 03/23/1989 | WO1989002220A1 Method and composition for enhancing animal fertility |
| 03/22/1989 | EP0307513A2 Pulmonary hydrophobic surfactant-associated proteins |
| 03/21/1989 | US4814435 Method of producing a factor VIII (AHF) containing fraction |
| 03/21/1989 | US4814434 Inducer of T-suppressor cells |
| 03/21/1989 | US4814171 Novel cosmetic compositions |
| 03/15/1989 | EP0307373A2 Purification process |
| 03/15/1989 | EP0307277A1 Product on a silanol basis for the care of the superficial lymphatic vessels |
| 03/15/1989 | EP0307002A1 Method for producing an antithrombin III concentrate |
| 03/15/1989 | EP0306778A2 Process for sterilizing plasma or plasma fractions |
| 03/15/1989 | CN1031714A Prepn. for a tonic zhang zhu liquor |
| 03/15/1989 | CN1031654A Pharmaceutical composition for prevention and treatment of disease caused by bacteria or virus |
| 03/15/1989 | CN1031653A Process for the production of dried earthworm powder and antihyperlipemic antidiabetic antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient |
| 03/15/1989 | CN1031652A Fluid for burnt skin regeneration |
| 03/14/1989 | US4812444 Dehydration of hydrous matter using anhydrous glycosylfructose |
| 03/14/1989 | US4812441 Hypocholesterolemically active protein derived from streptococcus |
| 03/14/1989 | US4812310 Citric acid, sodium citrate, glucose, glycering and mannitol |
| 03/14/1989 | EP0296205A4 Method and composition for hair growth in common pattern baldness. |
| 03/14/1989 | CA1251152A2 Ultrapurification of factor viii |
| 03/14/1989 | CA1251142A1 Process for producing storable camomile extracts rich in active substances |
| 03/14/1989 | CA1251134A1 Biologically active substance with hormonal properties, process for its production and application of histones for medical purposes |
| 03/09/1989 | WO1989001970A2 Transformed lactic acid bacteria |
| 03/09/1989 | WO1989001947A1 Protein derived from living body |
| 03/08/1989 | EP0306360A1 Method for the preparation of antigenic fractions used in the detection of antibodies indicative of cardiovascular trouble, antigenic fractions thus obtained and their use in the diagnosis of a cardiovascular risk |
| 03/08/1989 | EP0306282A2 Antiviral compositions derived from marine sponge epipolasis reiswigi and their methods of use |
| 03/08/1989 | EP0306132A1 Protecting biological material against chilling injury |
| 03/08/1989 | EP0305468A1 B-cell growth and differentiating factor BCGF 12K for use in therapy |
| 03/07/1989 | US4810827 Dehydration of hydrous matter using anhydrous aldohexose |
| 03/07/1989 | US4810780 Protein having phospholipase A2 inhibitory activity |
| 03/07/1989 | US4810691 Polypeptide cartilage-inducing factors found in bone |
| 03/07/1989 | US4810496 Treatment of skin and inflammatory disorders |
| 03/07/1989 | US4810495 Culture product |
| 03/07/1989 | US4810394 Process and apparatus for removing solid material including blood cells from whole blood |
| 03/01/1989 | EP0304897A2 Process for immunizing the human body at HIV infections |
| 03/01/1989 | EP0304431A1 Apparatus for plasmapheresis. |
| 03/01/1989 | CN1031326A Method for preventing fish and shrimp diseases by using haloplankton as living drug carrier |
| 02/28/1989 | US4808151 Simplified method for the preparation of human lymphokine activated killer cells |
| 02/28/1989 | CA1250523A1 Conjugates elaborated by binding a ligant to an isoluble medium, preparation process and biological uses |
| 02/23/1989 | WO1989001517A1 Vector for integration site independent gene expression in mammalian host cells |
| 02/23/1989 | WO1989001511A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |